Literature DB >> 12725330

Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.

S Fujii1, T Fujimori, T Chiba.   

Abstract

Patients with ulcerative colitis (UC) have a higher incidence of colorectal cancer. UC-associated colorectal cancer is thought to develop in patients with preexisting UC-associated dysplasia. It is crucial to diagnose UC-associated dysplasia and early stage of cancer in patients with long-standing UC for the purpose of treatment of UC-associated neoplasia. However, it is difficult to detect UC-associated dysplasia and the early stage of cancer endoscopically, and to discriminate these neoplasias from inflammatory regenerative epithelium pathologically. The aim of this study was to clarify whether observation of the surface microstructure could aid in the detection of UC-associated neopalsia, and whether analysis of genetic alterations could be used to discriminate between UC-associated neoplasia and inflammatory regenerative epithelium. Tissue samples were obtained from colectomy specimens from eight cases of UC-associated neoplasia. We examined the surface microstructure of these tissues using stereomicroscopy. We also investigated mutation of K-ras codon 12 using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and alteration of the p53 gene, using immunohistochemistry and PCR-single stranded conformation polymorphism (PCR-SSCP). The surface microstructure of UC-associated neoplasia revealed a packed distribution of oval and/or, club-shaped and/or, branch-shaped pits and a villous appearance. Nuclear accumulation of p53 protein occurred in 59.5% of UC-associated neoplasia. Mutations of the p53 exon 5-8 were detected in 95.2% of UC-associated neoplasia, and these mutations were detected in 92.9% of UC-associated neoplasia that showed negative p53 immunohistochemical staining. Mutations of the p53 exon 5-8 in regenerative epithelium occurred infrequently. The K-ras mutation rate in UC-associated neoplasia was 7.4%. In conclusion, immunohistochemistry and PCR-SSCP analysis of p53 would be useful tools for pathological discrimination between UC-associated neoplasia and inflammatory regenerative epithelium, and observation of the surface microstructure may contribute to accurate endoscopic detection of UC-associated neoplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725330

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  11 in total

Review 1.  Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis.

Authors:  Sigrun Thorsteinsdottir; Thorkell Gudjonsson; Ole Haagen Nielsen; Ben Vainer; Jakob Benedict Seidelin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

2.  A case of lymphoepithelioma-like carcinoma of the colon with ulcerative colitis.

Authors:  Yasuyuki Kojima; Masatoshi Mogaki; Ryo Takagawa; Ikuko Ota; Mitsutaka Sugita; Shiho Natori; Yohei Hamaguchi; Haruki Kurosawa; Tadao Fukushima; Hidenobu Masui; Shingo Fukazawa; Shoji Yamanaka; Yukio Tsuura; Kaoru Nagahori
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

3.  Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis.

Authors:  S Fujii; K Tominaga; K Kitajima; J Takeda; T Kusaka; M Fujita; K Ichikawa; S Tomita; Y Ohkura; Y Ono; J Imura; T Chiba; T Fujimori
Journal:  Gut       Date:  2005-05-03       Impact factor: 23.059

4.  Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran.

Authors:  Salaheddin Vaji; Zivar Salehi; Keyvan Aminian
Journal:  Int J Colorectal Dis       Date:  2010-07-29       Impact factor: 2.571

5.  Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.

Authors:  S Fujii; T Fujimori; H Kawamata; J Takeda; K Kitajima; F Omotehara; T Kaihara; T Kusaka; K Ichikawa; Y Ohkura; Y Ono; J Imura; S Yamaoka; C Sakamoto; Y Ueda; T Chiba
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Lack of thrombospondin-1 increases angiogenesis in a model of chronic inflammatory bowel disease.

Authors:  Samantha Zak; John Treven; Nolly Nash; Linda S Gutierrez
Journal:  Int J Colorectal Dis       Date:  2007-11-28       Impact factor: 2.571

7.  Immunohistochemical analysis of the DNA methyltransferase 3b expression is associated with significant improvements in the discrimination of ulcerative colitis-associated neoplastic lesions.

Authors:  Hirofumi Ueda; Hiroyuki Tanaka; Kazuhito Ichikawa; Michio Itabashi; Shingo Kameoka; Shigehiko Fujii; Natsuko Saito; Ryusuke Kimura; Yosuke Shida; Yukari Fujimori; Shinichirou Ohtake; Shigeki Tomita; Johji Imura; Yoshikazu Yasuda; Nobuhiko Tanigawa; Kazuhisa Uchiyama; Takahiro Fujimori
Journal:  Surg Today       Date:  2013-01-10       Impact factor: 2.549

8.  Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age.

Authors:  Constantine J Karvellas; Richard N Fedorak; John Hanson; Clarence K W Wong
Journal:  Can J Gastroenterol       Date:  2007-07       Impact factor: 3.522

9.  p53 codon 72 polymorphism in patients affected with ulcerative colitis.

Authors:  Maria Teresa Vietri; Gabriele Riegler; Antonietta Ursillo; Luigi Caserta; Michele Cioffi; Anna Maria Molinari
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 6.772

10.  Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry.

Authors:  Shunsuke Kobayashi; Takahiro Fujimori; Hiroyuki Mitomi; Shigeki Tomita; Kazuhito Ichikawa; Johji Imura; Shigehiko Fujii; Michihiro Itabashi; Shingo Kameoka; Yoshinori Igarashi
Journal:  Diagn Pathol       Date:  2014-05-29       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.